ArticlePatient preference and adherence2020

Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States.

Tracey Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.